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Conclusion: Presence of a chronic obstructive pulmonary disease is asso-
ciated with a doubling risk of all-cause death in CAD pts.
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Introduction: In degenerative mitral regurgitation (MR), brain natriuretic
peptide (BNP) is a surrogate biomarker of the consequences of MR on the left
ventricle (LV) and left atrium (LA). LV global longitudinal strain (GLS),
quantified by 2-D speckle-tracking imaging (2DSt) improved the detection of
subclinical LV dysfunction. We aimed evaluating the impact of BNP on out-
come and its relationship with GLS, in asymptomatic patients with degenera-
tive MR.
Method and results: Comprehensive transthoracic echocardiography
including 2DSt quantification was performed in 135 consecutive asymptom-
atic patients with moderate to severe degenerative MR and preserved LV
function. BNP was correlated with age (r=0.28, p=0.009), indexed LV end-
systolic diameter (r=0.30, p=0.0006), indexed LA volume (r=0.51, p<0.0001),
E/Ea ratio (r=0.33, p<0.0001), systolic pulmonary pressure (r=0.24, p=0.006)
and GLS (r=–0.54, p<0.0001). On multiple regression analysis, only indexed
LA volume and GLS were independently associated with BNP (=1.1±0.4,
p=0.002 and =–6.6±1.4, p<0.001, respectively). According to the median of
BNP, patients with high BNP level had significant reduced event-free survival
(21±8% vs. 75±6%, p<0.0001). A GLS<23% was also associated with lower
event-free survival (85±6% vs. 33±7%, p<0.0001). In Cox multivariate anal-
ysis, after adjustment for age, sex, E/Ea ratio and indexed end-systolic diam-
eter, only indexed LA volume (hazard ratio [HR]=1.01, 95% confidence
interval [CI]: 1.0-1.3, p=0.036), GLS<23% (HR=3.3, 95% CI: 1.1-9.9,
p=0.03) and BNP<41 pg/ml (HR=3.5, 95%CI: 1.7-7.2, p=0.001) were inde-
pendent determinants of cardiac event-free survival.
Conclusion: In asymptomatic degenerative MR, LV longitudinal function
and LA volume are the main determinants of BNP release. BNP is a powerful
independent predictor of cardiac events. Assessment of plasma BNP level, LA
volume, and LV longitudinal function may help to improve risk stratification
and the management of these patients.
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Background: Detection of high-risk patients is an important issue for the
management of aortic valve stenosis (AS). Previous studies have shown that
plasma levels of BNP increases with AS severity and may provide prognostic
information. However, these studies were impeded by selection bias and inclu-
sion of relatively young patients, or their small sample sizes. In addition, a
wide overlap of BNP values between symptomatic and asymptomatic patients
was observed. Thus, the aim of the present study was to evaluate the prognosis
value of BNP in a cohort of elderly patients with AS.
Method: Nt-proBNP was measured at entry in the study and patients were
prospectively followed on a yearly basis. Inclusion criteria were age 70
years, at least mild AS, absence of symptoms, and absence of significant renal
insufficiency.
Results: 346 patients were included. Mean age was 79±6 years. 225 had
severe AS and 196 were symptomatic. Nt-proBNP increases with NYHA class
and hemodynamic parameters (p<0.0001). However, Nt-proBNP values were
widely scattered with a large overlap between symptomatic and asymptomatic
patients. Consequently, Nt-proBNP had poor sensibility and specificity for the
detection of patients with severe symptomatic AS (ROC curve =0.73, sensi-
tivity=47%, specificity=85%). Among the 150 asymptomatic patients, 12
underwent a prophylactic surgery and follow-up was in 126 (91%). Patients
with NT-proBNP<300 pg/ml had a better outcome than patients with Nt-
proBNP between 300 and 700 pg/ml, or >700 pg/ml (99% vs. 90% and 86%
event free survival at one year, p=0.004). However, Nt-proBNP was not an
independent predictor of outcome after adjustment for valve area, age and
gender (p=0.30).
Conclusion: Our study is the first to enhance the limits of Nt-proBNP for
the evaluation of AS patients. Our data show that Nt-proBNP is not an inde-
pendent prognostic factor of outcome and raises caution regarding a patients’
management based on BNP value especially in the elderly population.
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Objectives: The human matrix associated serine protease inhibitor “tissue
factor pathway inhibitor-2” (TFPI-2) is known to have inhibitory activity
towards matrix metalloproteases (MMPs), which play an important role in the
process of aortic valve stenosis (AS). Reduced synthesis of TFPI-2 has been
related to numerous pathophysiological processes such as atherosclerosis.
Since AS is an atherosclerosis-like process, we hypothesized that TFPI-2
might play a protective role in the progression of AS.
Methods: Calcified aortic valves (n=28) were obtained from patients
undergoing aortic valve replacement (16 men; 68.7±2.2 years;indexed aortic
valve area 0,42±0,03 cm²/m²). Valvular expression and localization of TFPI-2
and other components of atherosclerosis were evaluated by immunohis-
tochemistry. TFPI-2 expression was further analyzed using a home-made
ELISA and by Western blot. Finally, we evaluated TFPI-2 expression in pri-
mary valve myofibroblast cultures obtained from explanted valves after colla-
genase digestion (n=12).
Results: We demonstrated TFPI-2 expression in aortic valves, which was
found to be significantly lower in the calcified regions as compared to non cal-
cified zones (1705±266 vs 2997±433 pg/mg; p=0.001). In contrast, there was
an overexpression in calcified regions as compared to non calcified zones of
pro-atherosclerotic factors (tissue factor (837±131 vs 476±95 pg/mg; p=0.01)
and MMP9 (97±46 vs 38±7 pg/mg; p=0.04)) and pro-calcifying proteins
(osteopontin (46±11 vs 4.6±1.3 ng/mg; p<0.0005)). Finally we showed that
cultured valve myofibroblasts express variable amounts of TFPI-2, inducible
by IL-1 or TNF- stimulation. Baseline TFPI-2 expression seemed to be
inversely correlated to the degree of calcification of the valves.
Conclusion: We showed here for the first time, the presence of TFPI-2 in
calcified human aortic valves. The inverse correlation between TFPI-2 expres-
sion and valve calcification might suppose a protective role for TFPI-2 in
aortic valve disease.
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Long-term efficacy of percutaneous mitral commissurotomy for reste-
nosis after previous mitral commissurotomy
Claire Bouleti [Orateur] Bernard Lung, David Messika-Zeitoun, Dominique
Himbert, Eric Brochet, Grégory Ducrocq, Alec Vahanian, Bertrand Cormier
AP-HP, CHU Bichat-Claude-Bernard, Cardiologie, Paris, France
Purpose: Whether surgical or percutaneous, mitral commissurotomy is
hampered by late mitral restenosis. Percutaneous mitral commissurotomy
(PMC) can be used to treat restenosis. Series with long-term follow-up are
necessary to evaluate the usefulness of PMC in deferring surgery.
Methods: We studied 163 patients (pts) who underwent PMC because of
restenosis a mean period of 16±8 years after previous commissurotomy
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(closed-heart in 121, open-heart in 30, and PMC in 12). Mean age was
48±14 years. Valve calcification was present in 62 pts (38%). The mechanism
of restenosis was bilateral commissural fusion.
Results: After PMC, valve area increased from 1.1±0.2 to 1.8±0.3 cm².
Severe mitral regurgitation occurred in 9 pts (5.5%). Good immediate results
(IR) (valve area1.5 cm² with MR2/4) were obtained in 135 pts (83%).
The 18-year rate of good functional results (survival without reintervention
on the mitral valve and in NYHA class I or II) was 19±4%. After good IR, the
rate of good functional results was 58±4% at 10 years and 23±5% at 18 years.
Multivariate predictive factors of poor late functional results were higher ini-
tial NYHA class (p=0.02), initial atrial fibrillation (p<0.001), and higher mean
mitral gradient after PMC (p=0.004).
Conclusion: 1) In selected pts with restenosis after previous mitral com-
missurotomy, PMC provides good IR in the majority of them 2) After good
IR, sustained functional improvement is present in almost one out of 4 pts
after 18 years, enabling reoperation to be deferred in more than half of pts
after 10 years. 3) Predictive factors of late results provide relevant information
for patient selection.
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Background: About 15 to 25% of patients with severe aortic stenosis (AS)
(aortic valve area, AVA1 cm²) have a low transvalvular flow and a low mean
gradient (< 40 mmHg) despite preserved left ventricular ejection fraction
(LVEF). This entity, named paradoxical low flow, low gradient (PLFLG) AS,
was initially described using Doppler-echocardiography. However, some con-
cerns were raised about potential overestimation of the prevalence of this
entity by echo. This study aimed to describe the prevalence and clinical char-
acteristics of patients with PLFLG AS using cardiac catheterization data.
Methods and Results: Between 1994 and 2010, 2005 patients underwent
cardiac catheterization for evaluation of AS severity and identification of cor-
onary artery disease prior to aortic valve replacement (AVR). Of these
patients, we excluded patients with other valvular heart disease or with a
LVEF <50%. Of the remaining 1296. 58% of patients had an AVA1 cm² and
a mean gradient >40 mm Hg (classical severe AS), whereas 23% had an
AVA 1 cm² but a mean gradient <40mm Hg (PLFLG AS); the remaining
16% were considered not having severe AS and 2% had an AVA >1 cm² and
a mean gradient >40 mmHg. In comparison to the patients with Classical
severe AS, those with PLFLG AS were significantly older, more often female,
had lower cardiac output, higher systolic blood pressure, and pulmonary vas-
cular resistance (all p<0.05). The percentage of patients who finally underwent
AVR was significantly lower (85 vs. 95%) and that of patients who had con-
comitant CABG was higher (38 vs. 31%) in patients with PLFLG AS.
Conclusion: This large cardiac catheterization dataset shows that PLFLG
severe AS is a frequent entity that afflicts up to 23% of the patients with
severe AS referred to AVR. These patients had more frequent co-morbidities.
These findings further underlines the importance to correctly identify this
entity so we do not deny surgery to patients with a small AVA and a low gra-
dient despite preserved LVEF.
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The surgical management of valvular heart disease is usually assessed in
terms of mortality, morbidity, operative and post operative that are often inad-
equate. Few studies have investigated the impact of this heavy surgery on
patients quality of life, the aim of our study is to examine the real benefit of
surgical treatment of rheumatic valvular heart disease by assessing the quality
of life before and 3 months after surgery. This is a prospective study per-
foremed on Cardiology and Cardiovascular Surgery departments of University
Hospital Mohamed VI in Marrakech, over a period of five months (May-
October 2010) The study is still continued.
Patiens and methods: We included all patients aged under 40 candidates
for valve replacement surgery for rheumatic valvulopathy. Quality of life was
assessed by validated Arabic version of the SF 36 score.
Results: 52 patients, mean age 33 years (30 women/22 hommes), symp-
tomatic NYHA IV of 75%, atrial fibrillation in 71%. The period of operability
after surgical indication ranged from 6 months to 3 years. It was a mitral dis-
ease in 38%, 36% mitral stenosis and aortic disease in 11% of cases. Analysis
of SF-36 score before surgery is on average 40 on a scale (0-100), spent on
average to 66.4 after surgery and ranged from 45 to 80. Improving quality of
life was concerned mainly moderate activities (items 4-5-7-8). The factors
identified as influencing the quality of life after replacement: the nature of the
valvular disease, its severity, it is an isolated or associated, the dimensions and
left ventricular systolic function preoperatively.
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We suggest that longitudinal left ventricular function assessed by mitral
annular velocities and apical mitral annulus motion would improve after relief of
mitral stenosis and that serial assessment could be used as an index for quantifying
functional changes after percutaneous mitral commissurotomy (PMC).
Methods: Longitudinal left ventricular annular velocities were quantified
by spectral pulsed wave Doppler tissue velocity imaging in 62 patients
(48 women; mean age 45+/–10 years who had isolated mitral stenosis and
were in sinus rhythm. Echocardiography was performed 1 to 24 hours before
PMC and 24 hours, 1 and 3 months after.
We recorded changes in velocities from the lateral and septal corners of the
mitral annulus in early diastole, late diastole, volume and systolic function of
the left and right ventricular, the maximal and minimal volume and the ejec-
tion fraction (EF) of the left atrium by the Simpson method.
Results: After PMC we relieved a decrease in the left atria volume and an
improvement of the left ventricular EF (28.8±12% a 39.20%, p=0.003), an
increase of the left ventricular systolic volume (31.11 vs 52±35 ml, p=0.003)
The peak annular velocity of systolic excursion in ejection and the mitral
annulus motion showed a significant improvement they were respectively at
6.5±1.1 vs 7.9±1.0, p=0.001 and 9.5±1.4 vs 12.6±2, p=0.02). The change in
peak annular velocity in the lateral wall correlated well with improvement in
the mitral valve orifice area by planimetry (r=0.953, p=0.04), and inversely
correlated with the thickness of the mitral leaflet (r=–0.953, p=0.04).
Conclusion: Serial evaluation of changes in mitral annular velocities and
annulus motion by Doppler tissue imaging aids clinical assessment of immediate
improvement in left ventricular function after PMC.This changes are correlated to
the anatomy valve and to the improvement of the left ventricular load.
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Objectives: To clarify the impact of gender difference in transcatheter aortic
valve implantation (TAVI) for high-risk patients with severe aortic stenosis.
